Thyroid Gland Disorder Treatment Market to Reach $2,771 Mn,Globally,by 2025 - PowerPoint PPT Presentation

About This Presentation
Title:

Thyroid Gland Disorder Treatment Market to Reach $2,771 Mn,Globally,by 2025

Description:

The global thyroid gland disorder market is estimated to reach $2,771 million at a CAGR of 3.8% from 2018 to 2025. North America was the highest contributor to the thyroid gland disorder treatment market in 2017; however, Asia-Pacific is expected to witness the highest growth during the forecast period. – PowerPoint PPT presentation

Number of Views:75

less

Transcript and Presenter's Notes

Title: Thyroid Gland Disorder Treatment Market to Reach $2,771 Mn,Globally,by 2025


1
Thyroid Gland Disorder Treatment Market
Opportunity Analysis and Industry Forecast,
2016-2023
Global Opportunity Analysis and Industry
Forecast, 2017-2025
2
Introduction of Thyroid Gland Disorder Treatment
Market
The global thyroid gland disorder market was
valued at 2,057 million in 2017, and is
estimated to reach 2,771 million at a CAGR of
3.8 from 2018 to 2025. North America was the
highest contributor to the thyroid gland disorder
treatment market in 2017 however, Asia-Pacific
is expected to witness the highest growth during
the forecast period. The thyroid gland produces
hormones, which regulates the body metabolism.
The abnormal release of thyroid hormones causes
thyroid disorder. Thyroid hormone is necessary to
regulate the heart rate, blood pressure, and body
temperature. However, due to factors such as
iodine deficiency, autoimmunity, and congenital
hypothyroidism, one-third of the population is at
the risk of having thyroid disease. The major
factors that drive the growth of the thyroid
gland disorder market include increase in
incidence of thyroid gland disorders, development
of effective combination thyroid disorders drug
therapies, and increase in number of disease
awareness programs in developing regions.
3
Introduction of India Aerospace Coating Market
Scope of
the Report
Key Benefits Key Audiences
4
 
Key Benefits
  • The Liothyronine segment is projected to grow at
    the highest rate among the drug type segment
    during the analysis period.
  • North America dominated global thyroid gland
    disorder treatment market in 2017, and is
    projected to continue its dominance in future.
  • China is expected to grow at the highest rate in
    Asia-Pacific during the forecast period.
  • Wholesaler/distributor is the largest contributor
    among the distribution channels segments in 2017.
  • The hypothyroidism segment generated the highest
    revenue, and is expected to continue its
    dominance in future.

5
 
Table of Content (TOC)
Chapter 1 Introduction Chapter 2 Executive
Summary Chapter 3 Market Overview Chapter 4
Thyroid Gland Disorder Treatment Market, By
Disease Type Chapter 5 Thyroid Gland Disorder
Treatment Market, By Drug Type Chapter 6
Thyroid Gland Disorder Treatment Market, By Route
Of Administration Chapter 7 Thyroid Gland
Disorder Treatment Market, By Distribution
Channel Chapter 8 Thyroid Gland Disorder
Treatment Market, By Geography Chapter 9
Company Profiles
6
 
Segments Thyroid Gland Disorder Treatment Market
7
 
Segments Thyroid Gland Disorder Treatment Market
8

Segments Thyroid Gland Disorder Treatment Market
9
 
Company Profiles Thyroid Gland Disorder Treatment
Market
  1. Abbott Laboratories
  2. AbbVie Inc.
  3. Allergan Plc.
  4. GlaxoSmithKline plc
  5. Lannett Company, Inc.
  6. Merck Co. Inc.

10
Thank You!
For More Details
Thank You Thyroid Gland Disorder Treatment Market
Do Enquiry
https//www.alliedmarketresearch.com/thyroid-gland
-disorder-treatment-market
Follow Us On
Write a Comment
User Comments (0)
About PowerShow.com